The 52-Week Low Club for Monday

April 11, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Monday’s session. The day’s NYSE winners led losers by about 3-to-2. Nasdaq winners to losers were essentially even at the bell.

Under Armour Inc. (NYSE: UA) posted a new 52-week low on Monday. Shares traded at a low of $41.00, down about 5.8%, after closing at $43.54 on Friday. The stock’s 52-week high is $105.89. Volume totaled more than 3 times the daily average of around 4 million shares. Analysts at Morgan Stanley had so woeful words on sale, including a drop of 7% in women’s apparel sales.

Endo International plc (NASDAQ: ENDP) fell by about 9.3% on Monday to post a new 52-week low of $25.67 against a high of $96.58. The stock closed at $28.30 on Friday night. Volume totaled  more than 10 million shares, more than 50% above the daily average of about 6.3 million. The drugmaker suffered from a knock-on effect following Insys’s announcement of lower sales for its opioid painkiller.

Allergan plc (NYSE: AGN) dropped about 4.4% on Monday to post a new 52-week low of $225.60 against a 52-week high of $340.34. The stock closed at $236.00 on Friday night. Volume was nearly double the stock’s daily average volume of around 4.1 million. Chatter suggest that the company might try to soothe its bruises from the busted deal with Pfizer buy making an offer for Endo. That makes little sense because Allergan is selling its stake in generics maker Teva, and Endo gets half or more of its sales from generics.

24/7 Wall St.
5 Biotechs With the Most Upside This Earnings Cycle

Clovis Oncology Inc. (NASDAQ: CLVS) dropped about 8.8% on Monday to post a new 52-week low at $14.38 after closing at $15.77 on Friday. The stock’s 52-week high is $116.75. Share volume of around 4 million was more than 3 times the daily average of about 1.3 million shares traded. Reuters reported that FDA reviewers want the company’s new cancer drug to carry a black-box warning.